Modification of the size of developing infarcts in the ligated dog heart by betahistine-hcl

Louis Terracio, William G. Kubicek

Research output: Contribution to journalArticle

Abstract

The effectiveness of ß-histine-HCl in modifying the size of developing myocardial infarcts was tested in the surgically ligated dog. Branches of the left coronary artery were ligated and a 6-hour continuous intravenous infusion of 0.24 mg/kg/min of ß-histine was administered from 0 to 120 min after ligation. The effect of this treatment was evaluated histologically in studies on acute ischemia by the use of the hematoxylin-basic fuchsin-picric acid stain for early myocardial ischemia. The treatment was also evaluated grossly in a study on chronic ischemia where the dogs were permitted to survive for 30 days before sacrifice. In these experiments, the size of infarcts found in the ß-histine-treated animals was compared with those found in the saline controls. Both studies showed that the control ligations produced a large uniform area of ischemia or infarction that was greatly reduced or prevented by immediate treatment with ß-histine. Also, ß-histine was capable of significantly reducing the size of developing infarcts for up to 120 min after ligation.

Original languageEnglish (US)
Pages (from-to)372-379
Number of pages8
JournalCells Tissues Organs
Volume101
Issue number4
DOIs
StatePublished - 1978

Fingerprint

Betahistine
Ligation
Ischemia
Dogs
Hematoxylin
Intravenous Infusions
Infarction
Myocardial Ischemia
Coronary Vessels
Coloring Agents
Therapeutics
Myocardial Infarction

Keywords

  • Collateral circulation
  • Heart
  • Myocardial infarction
  • ß-histine-HC1
  • Vasodilator

ASJC Scopus subject areas

  • Anatomy
  • Histology

Cite this

Modification of the size of developing infarcts in the ligated dog heart by betahistine-hcl. / Terracio, Louis; Kubicek, William G.

In: Cells Tissues Organs, Vol. 101, No. 4, 1978, p. 372-379.

Research output: Contribution to journalArticle

@article{36aae308b8e54ff68e41b20f5ed2ba5f,
title = "Modification of the size of developing infarcts in the ligated dog heart by betahistine-hcl",
abstract = "The effectiveness of {\ss}-histine-HCl in modifying the size of developing myocardial infarcts was tested in the surgically ligated dog. Branches of the left coronary artery were ligated and a 6-hour continuous intravenous infusion of 0.24 mg/kg/min of {\ss}-histine was administered from 0 to 120 min after ligation. The effect of this treatment was evaluated histologically in studies on acute ischemia by the use of the hematoxylin-basic fuchsin-picric acid stain for early myocardial ischemia. The treatment was also evaluated grossly in a study on chronic ischemia where the dogs were permitted to survive for 30 days before sacrifice. In these experiments, the size of infarcts found in the {\ss}-histine-treated animals was compared with those found in the saline controls. Both studies showed that the control ligations produced a large uniform area of ischemia or infarction that was greatly reduced or prevented by immediate treatment with {\ss}-histine. Also, {\ss}-histine was capable of significantly reducing the size of developing infarcts for up to 120 min after ligation.",
keywords = "Collateral circulation, Heart, Myocardial infarction, {\ss}-histine-HC1, Vasodilator",
author = "Louis Terracio and Kubicek, {William G.}",
year = "1978",
doi = "10.1159/000144988",
language = "English (US)",
volume = "101",
pages = "372--379",
journal = "Cells Tissues Organs",
issn = "1422-6405",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Modification of the size of developing infarcts in the ligated dog heart by betahistine-hcl

AU - Terracio, Louis

AU - Kubicek, William G.

PY - 1978

Y1 - 1978

N2 - The effectiveness of ß-histine-HCl in modifying the size of developing myocardial infarcts was tested in the surgically ligated dog. Branches of the left coronary artery were ligated and a 6-hour continuous intravenous infusion of 0.24 mg/kg/min of ß-histine was administered from 0 to 120 min after ligation. The effect of this treatment was evaluated histologically in studies on acute ischemia by the use of the hematoxylin-basic fuchsin-picric acid stain for early myocardial ischemia. The treatment was also evaluated grossly in a study on chronic ischemia where the dogs were permitted to survive for 30 days before sacrifice. In these experiments, the size of infarcts found in the ß-histine-treated animals was compared with those found in the saline controls. Both studies showed that the control ligations produced a large uniform area of ischemia or infarction that was greatly reduced or prevented by immediate treatment with ß-histine. Also, ß-histine was capable of significantly reducing the size of developing infarcts for up to 120 min after ligation.

AB - The effectiveness of ß-histine-HCl in modifying the size of developing myocardial infarcts was tested in the surgically ligated dog. Branches of the left coronary artery were ligated and a 6-hour continuous intravenous infusion of 0.24 mg/kg/min of ß-histine was administered from 0 to 120 min after ligation. The effect of this treatment was evaluated histologically in studies on acute ischemia by the use of the hematoxylin-basic fuchsin-picric acid stain for early myocardial ischemia. The treatment was also evaluated grossly in a study on chronic ischemia where the dogs were permitted to survive for 30 days before sacrifice. In these experiments, the size of infarcts found in the ß-histine-treated animals was compared with those found in the saline controls. Both studies showed that the control ligations produced a large uniform area of ischemia or infarction that was greatly reduced or prevented by immediate treatment with ß-histine. Also, ß-histine was capable of significantly reducing the size of developing infarcts for up to 120 min after ligation.

KW - Collateral circulation

KW - Heart

KW - Myocardial infarction

KW - ß-histine-HC1

KW - Vasodilator

UR - http://www.scopus.com/inward/record.url?scp=84940138596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940138596&partnerID=8YFLogxK

U2 - 10.1159/000144988

DO - 10.1159/000144988

M3 - Article

VL - 101

SP - 372

EP - 379

JO - Cells Tissues Organs

JF - Cells Tissues Organs

SN - 1422-6405

IS - 4

ER -